Jason Agulnik
- Internal Medicine top 5%
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 8
- Cancer Immunotherapy and Biomarkers 7
- Lung Cancer Research Studies 7
- Global Cancer Incidence and Screening 5
-
- Lung Cancer Treatments and Mutations 38
- Lung Cancer Diagnosis and Treatment 26
- Gastric Cancer Management and Outcomes 5
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 13
- Co-authors
- David SmallGoulnar KasymjanovaVictor CohenCarmela PepeV. CohenLama SakrWilson H. MillerVicky Tagalakis
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Jason Agulnik
61 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 86
- Internal Medicine 80
- Oncology 506
- Pulmonary and Respiratory Medicine 580
- Cancer Research 167
- Pathology and Forensic Medicine 110
Countries citing papers authored by Jason Agulnik
This map shows the geographic impact of Jason Agulnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Agulnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Agulnik more than expected).
Fields of papers citing papers by Jason Agulnik
This network shows the impact of papers produced by Jason Agulnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Agulnik. The network helps show where Jason Agulnik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jason Agulnik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 3 | |
| 8 | 2022 | 27 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 20 | |
| 11 | 2018 | 6 | |
| 12 | 2018 | 10 | |
| 13 | 2018 | 1 | |
| 14 | 2015 | 9 | |
| 15 | 2015 | 88 | |
| 16 | 2014 | 7 | |
| 17 | 2013 | 115 | |
| 18 | HEALTH-RELATED QUALITY OF LIFE IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS | 2012 | 1 |
| 19 | 2010 | 1 | |
| 20 | 2008 | 24 |
About Jason Agulnik
Jason Agulnik is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 68 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Diagnosis and Treatment (26 papers), Cancer Genomics and Diagnostics (13 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Research Studies (7 papers), Gastric Cancer Management and Outcomes (5 papers) and Global Cancer Incidence and Screening (5 papers). The work is most often cited by research in Internal Medicine (80 citations), Oncology (506 citations) and Pulmonary and Respiratory Medicine (580 citations). Jason Agulnik has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include David Small, Goulnar Kasymjanova, Victor Cohen, Carmela Pepe, V. Cohen, Lama Sakr, Wilson H. Miller, Vicky Tagalakis, Gerald Batist and George Chong.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.